Examples of Provisional Application in a sentence
Performance of and decisions taken in relation to any notified invention, Provisional Application, Full Application or Later Application may be recorded and approved in accordance with the template set out in Schedule 5.
US Utility Patent Application, Serial No. 10/391,221, filed on March 17th, 2003, claiming priority from US Provisional Application, Serial No. 60/365,662, filed on March 15th, 2003.
Xxxx, Ph.D., Priority Filing Date: 11/24/2003 – Application No. 06104637.5 UMMC 06-38 Invention Disclosure Entitled: “Design, Synthesis, and Formulation of Nanotransporters for Efficient Nucleic Acids and other Pharmaceutics Delivery in Cells and Animals Provisional Application Entitled: “Nanotransporters for Efficient Delivery of Nucleic Acid and Other Pharmaceutical Agents” Txxxx X.
Xxxx, Ph.D. and Zxxxxxxx Xx. Provisional Application Entitled: “Improved RNA Interference Agents for Therapeutic Use” Txxxx X.
Xxxx, Ph.D., Filed 1/26/2006 – Application No. 60/762,956 UMMC 06-39 Invention Disclosure Entitled: “Therapeutic Silencing of Genes Involved in Cholesterol Biosynthesis and Other Metabolic Disorders by Chemically Modified siRNA and New Delivery Agents” Provisional Application Entitled: “Improved RNA Interference Agents for Use in Therapy of Metabolic Disorders” Txxxx X.
Systems and Methods for Fabricating Crystals of Metal Compounds (which was a conversion from U.S. Provisional Application 63/223,731, filed with the U.S. Patent Office to secure a July 20, 2022 filing date.) (PATENT PENDING) Expected to expire July 2041.Government and Environmental Regulations US manufacturers of semiconductor materials are required to comply with a range of governmental regulations related to the environment, worker health and safety, consumer protection, and privacy.
Xxxx, Ph.D., inventor Filed 11/15/02 — Application No. 60/426,982 UMMC 03-101 Invention Disclosure Entitled “RNAi Modifications” Provisional Application “In Vivo Gene Silencing by Chemically Modified and Stable siRNA” Txxxx X.
Xxxx, Ph.D. inventor Filed 9/25/02 — Application No. 60/413,529 UMMC 03-61 Invention Disclosure Entitled “In Vivo Gene Silencing by Chemically Modified and Stable siRNA” Provisional Application “In Vivo Gene Silencing by Chemically Modified and Stable siRNA” Txxxx X.
Xxxxxxxxx Acting Director, OTM Chief Executive Officer EXHIBIT A List of Patent Rights UMMC 03-33 Invention Disclosure Entitled “Chemically Modified siRNA and Uses Thereof Provisional Application “Chemically Modified siRNA and Uses Thereof Txxxx X.
XxXxxxxx, Ph.D., Name: Txx Xxxxx, Ph.D. Title: Executive Director, Office of Technology Management Title: President & CEO Date: Date: EXHIBIT A Patent Rights UMMC 03-68 Invention Disclosure Entitled: “Methods of efficient siRNA delivery in human cells — new approaches for the development of siRNA therapeutics” Provisional Application Entitled: “Delivery of siRNAs” Txxxx X.